Capstone Investment Advisors
OSIR

Capstone Investment Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Capstone Investment Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40,196
Closed -$764K – 1491
2019
Q1 		$764K Buy
+40,196
New +$652K 0.01% 891

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Capstone Investment Advisors's OSIR Position: Q2 2019 in Review

Capstone Investment Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 40,196 shares — an estimated $764K sold.

Capstone Investment Advisors first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $764K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Capstone Investment Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Capstone Investment Advisors sold 40,196 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $764K.
  • Capstone Investment Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Capstone Investment Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $764K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Capstone Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.